Why the study?
What is the status of ERAS protocol implementation and adherence in gynecologic oncology across Europe?
What is the status of ERAS protocol implementation and adherence in gynecologic oncology across Europe?
Despite broad implementation of ERAS protocols in European gynecologic oncology, adherence to specific protocol items remains highly variable.
Variable ERAS adherence despite broad implementation may limit benefits in gynecologic oncology; leaves open effects on outcomes and optimal standardization strategies.
This survey shows broad implementation of ERAS protocols across Europe; however, a wide variation in adherence to the various ERAS protocol items was reported.
No takes yet. Share an insight, caveat, or question.
Gómez‐Hidalgo et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: